Thromboembolism in pediatric inflammatory bowel disease: Systematic review

Marzia Lazzerini, Matteo Bramuzzo, Massimo Maschio, Stefano Martelossi, Alessandro Ventura

Research output: Contribution to journalArticle

Abstract

Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We searched Medline, LILACS, EMBASE, POPLINE, CINHAL, and reference lists of identified articles, without language restrictions, in August 2010. Results: Population studies suggest that there is an increased risk of TE in children with IBD compared to controls. TE occurred in children with IBD in all age ranges, mostly (82.8%) during active disease, and more frequently in children with ulcerative colitis (odds ratio [OR] 3.7, 95% confidence interval [CI] 1.8-7.6). At least one specific risk factor for TE was recognized in 50% of cases; two risk factors were present in 24%. Out of 92 published cases of TE in children with IBD, 54.3% occurred in cerebral site, 26% in the limbs, 13% in the abdominal vessels, and the remaining in the retina and lungs. After a first episode of TE, an early recurrence was observed in 11.4% of children, a late recurrence in 10%. A number of different therapeutic schemes were used. Overall mortality was 5.7% and was mostly associated with cerebral TE. Conclusions: Population studies are needed to clarify the risk of TE in children with IBD, the relative weight of other risk factors, the characteristics of the events, and to define guidelines of therapy and prophylaxis. (Inflamm Bowel Dis 2010)

Original languageEnglish
Pages (from-to)2174-2183
Number of pages10
JournalInflammatory Bowel Diseases
Volume17
Issue number10
DOIs
Publication statusPublished - Oct 2011

Fingerprint

Thromboembolism
Inflammatory Bowel Diseases
Pediatrics
Population
Recurrence
Venous Thromboembolism
Ulcerative Colitis
Retina
Cohort Studies
Language
Extremities
Odds Ratio
Guidelines
Confidence Intervals
Weights and Measures
Lung
Mortality
Therapeutics

Keywords

  • inflammatory bowel disease
  • pediatric
  • thromboembolism

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Thromboembolism in pediatric inflammatory bowel disease : Systematic review. / Lazzerini, Marzia; Bramuzzo, Matteo; Maschio, Massimo; Martelossi, Stefano; Ventura, Alessandro.

In: Inflammatory Bowel Diseases, Vol. 17, No. 10, 10.2011, p. 2174-2183.

Research output: Contribution to journalArticle

@article{463dd03888f042b3ae6a2b4d3804e64e,
title = "Thromboembolism in pediatric inflammatory bowel disease: Systematic review",
abstract = "Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We searched Medline, LILACS, EMBASE, POPLINE, CINHAL, and reference lists of identified articles, without language restrictions, in August 2010. Results: Population studies suggest that there is an increased risk of TE in children with IBD compared to controls. TE occurred in children with IBD in all age ranges, mostly (82.8{\%}) during active disease, and more frequently in children with ulcerative colitis (odds ratio [OR] 3.7, 95{\%} confidence interval [CI] 1.8-7.6). At least one specific risk factor for TE was recognized in 50{\%} of cases; two risk factors were present in 24{\%}. Out of 92 published cases of TE in children with IBD, 54.3{\%} occurred in cerebral site, 26{\%} in the limbs, 13{\%} in the abdominal vessels, and the remaining in the retina and lungs. After a first episode of TE, an early recurrence was observed in 11.4{\%} of children, a late recurrence in 10{\%}. A number of different therapeutic schemes were used. Overall mortality was 5.7{\%} and was mostly associated with cerebral TE. Conclusions: Population studies are needed to clarify the risk of TE in children with IBD, the relative weight of other risk factors, the characteristics of the events, and to define guidelines of therapy and prophylaxis. (Inflamm Bowel Dis 2010)",
keywords = "inflammatory bowel disease, pediatric, thromboembolism",
author = "Marzia Lazzerini and Matteo Bramuzzo and Massimo Maschio and Stefano Martelossi and Alessandro Ventura",
year = "2011",
month = "10",
doi = "10.1002/ibd.21563",
language = "English",
volume = "17",
pages = "2174--2183",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Thromboembolism in pediatric inflammatory bowel disease

T2 - Systematic review

AU - Lazzerini, Marzia

AU - Bramuzzo, Matteo

AU - Maschio, Massimo

AU - Martelossi, Stefano

AU - Ventura, Alessandro

PY - 2011/10

Y1 - 2011/10

N2 - Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We searched Medline, LILACS, EMBASE, POPLINE, CINHAL, and reference lists of identified articles, without language restrictions, in August 2010. Results: Population studies suggest that there is an increased risk of TE in children with IBD compared to controls. TE occurred in children with IBD in all age ranges, mostly (82.8%) during active disease, and more frequently in children with ulcerative colitis (odds ratio [OR] 3.7, 95% confidence interval [CI] 1.8-7.6). At least one specific risk factor for TE was recognized in 50% of cases; two risk factors were present in 24%. Out of 92 published cases of TE in children with IBD, 54.3% occurred in cerebral site, 26% in the limbs, 13% in the abdominal vessels, and the remaining in the retina and lungs. After a first episode of TE, an early recurrence was observed in 11.4% of children, a late recurrence in 10%. A number of different therapeutic schemes were used. Overall mortality was 5.7% and was mostly associated with cerebral TE. Conclusions: Population studies are needed to clarify the risk of TE in children with IBD, the relative weight of other risk factors, the characteristics of the events, and to define guidelines of therapy and prophylaxis. (Inflamm Bowel Dis 2010)

AB - Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We searched Medline, LILACS, EMBASE, POPLINE, CINHAL, and reference lists of identified articles, without language restrictions, in August 2010. Results: Population studies suggest that there is an increased risk of TE in children with IBD compared to controls. TE occurred in children with IBD in all age ranges, mostly (82.8%) during active disease, and more frequently in children with ulcerative colitis (odds ratio [OR] 3.7, 95% confidence interval [CI] 1.8-7.6). At least one specific risk factor for TE was recognized in 50% of cases; two risk factors were present in 24%. Out of 92 published cases of TE in children with IBD, 54.3% occurred in cerebral site, 26% in the limbs, 13% in the abdominal vessels, and the remaining in the retina and lungs. After a first episode of TE, an early recurrence was observed in 11.4% of children, a late recurrence in 10%. A number of different therapeutic schemes were used. Overall mortality was 5.7% and was mostly associated with cerebral TE. Conclusions: Population studies are needed to clarify the risk of TE in children with IBD, the relative weight of other risk factors, the characteristics of the events, and to define guidelines of therapy and prophylaxis. (Inflamm Bowel Dis 2010)

KW - inflammatory bowel disease

KW - pediatric

KW - thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=80052727980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052727980&partnerID=8YFLogxK

U2 - 10.1002/ibd.21563

DO - 10.1002/ibd.21563

M3 - Article

C2 - 21910180

AN - SCOPUS:80052727980

VL - 17

SP - 2174

EP - 2183

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 10

ER -